# Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients

> **NCT06873360** · — · COMPLETED · sponsor: **Corporacion Parc Tauli** · enrollment: 50 (actual)

## Conditions studied

- Peripheral Neuropathy Due to Chemotherapy

## Interventions

- **OTHER:** Clinical interviews with patients and Usability interviews and glove testing.

## Key facts

- **NCT ID:** NCT06873360
- **Lead sponsor:** Corporacion Parc Tauli
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-01
- **Primary completion:** 2025-11-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06873360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06873360, "Medical Device for Oxaliplatin-Induced Neuropathy in Gastrointestinal Cancer Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06873360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*